Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$2.18 - $4.29 $73,069 - $143,792
-33,518 Closed
0 $0
Q3 2020

Nov 17, 2020

SELL
$3.46 - $8.39 $12,788 - $31,009
-3,696 Reduced 9.93%
33,518 $204,000
Q1 2020

May 13, 2020

BUY
$2.46 - $5.84 $1,033 - $2,452
420 Added 1.14%
37,214 $99,000
Q3 2019

Nov 15, 2019

BUY
$8.12 - $14.54 $3,564 - $6,383
439 Added 1.21%
36,794 $446,000
Q2 2019

Aug 14, 2019

BUY
$9.6 - $22.85 $349,008 - $830,711
36,355 New
36,355 $416,000

Others Institutions Holding CYCN

# of Institutions
1
Shares Held
293K
Call Options Held
0
Put Options Held
0

About Cyclerion Therapeutics, Inc.


  • Ticker CYCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,479,800
  • Market Cap $137M
  • Description
  • Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...
More about CYCN
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.